1106732

Inspection Details

Classification

No Action Indicated (NAI) (NAI)

End Date

September 26, 2019

Fiscal Year

2019

Product Type

Drugs

Project Area

Bioresearch Monitoring

Location

Minneapolis, MN (United States)

Additional Details